I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients

Thyroid

Volumn 21, Issue 11, 2011, Pages 1235-1247

  Blum, Manfred ^a   Tiu, Serafin ^a   Chu, Michael ^a   Goel, Sumina ^a   Friedman, Kent ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ABLATION THERAPY; ADULT; AGED; ARTICLE; BLADDER; CANCER SURGERY; CLINICAL ARTICLE; COLON; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; GALLBLADDER; GINGIVA; HIATUS HERNIA; HUMAN; IMAGE ANALYSIS; KIDNEY CYST; MALE; MENSTRUATION; METASTASIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIOACTIVITY; RECTUM; SIGMOID; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TERATOMA; THYMUS; THYROID CANCER; THYROIDECTOMY; TOOTH ABSCESS; UTERUS MYOMA; WHOLE BODY SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; WHOLE BODY IMAGING;

EID: 82955238829     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0010     Document Type: Article

References (48)

1. Omur O, Akgun A, Ozcan Z, Sen C, Ozkilic H 2009 Clinical implications of diffuse hepatic uptake observed in post-ablative and post-therapeutic I-131 scans. Clin Nucl Med 34:11-14.
2. Bhattacharya A,Venkataramarao SH, Bal CS, Mittal BR 2010 Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma. Indian J Nucl Med 25:29-31.
3. Ruf J, Lehmkuhl L, Bertram H, Sandrock D, Amthauer H, Humplik B, Ludwig MD, Felix R 2004 Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun 25:1177-1182. (Pubitemid 39614278)
4. Tharp K, Israel O, Hausmann J, Bettman L, Martin WH, Daitzchman M, Sandler MP, Delbeke D 2004 Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging 31:1435-1442. (Pubitemid 39361941)
5. Yamamoto Y, Nishiyama Y, Monden T, Matsumura Y, Satoh K, Ohkawa M 2003 Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med 44:1905-1910. (Pubitemid 40022135)
6. Belhocine T, Rachinsky I, Akincioglu C, Gambhir S, Wilcox B, Vezina W, Stitt L, Driedger A, Urbain JL 2008 How useful is an integrated SPECT/CT in clinical setting and research? Evaluation of a low radiation dose 4 slice system. Open Med Imag J 2:80-108.
7. Keidar Z, Israel O, Krausz Y 2003 SPECT/CT in tumor imaging: technical aspects and clinical application. Semin Nucl Med 33:205-218. (Pubitemid 36859499)
8. Chen L, Luo Q, Shen Y, Yu Y, Yuan Z, Lu H, Zhu R 2008 Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma. J Nucl Med 49:1952-1957.
9. Schmidt D, Szikszai A, Linke R 2008 Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J Nucl Med 50:18-23.
10. Wong KK, Zarzhevsky N, Cahill JM, Frey KA, Avram AM 2008 Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma. Am J Roentgenol 191:1785-1794.
11. Spanu A, Solinas ME, Chessa F, Sanna D, Nuvoli S, Ma-deddu G 2009 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging. J Nucl Med 50:184-190.
12. Aide N, Heutte N, Rame JP, Rousseau E, Loiseau C, Henry-Amar M, Bardet S 2008 Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation 131I scintigraphy for thyroid cancer. J Clin Endocrinol Metab 94:2075-2084.
13. Kohlfuerst S, Igerc I, Lobnig M, Gallowitsch HJ, Gomez-Segovia I, Matschnig S, Mayr J, Mikosch P, Beheshti M, Lind P 2009 Posttherapeutic 131 I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen. Eur J Nucl Med Mol Imaging 36:886-893.
14. Macdonald W, Armstrong J 2007 Benign struma ovarii in a patient with invasive papillary thyroid cancer: detection with I-131 SPECT-CT. Clin Nucl Med 32:380-382. (Pubitemid 46659174)
15. Schlumberger MJ, Pacini F 2009 The low utility of pre-therapy scans in thyroid cancer patients. Thyroid 19:815-816.
16. Van Nostrand D, Aiken M, Atkins F, Moreau S, Garcia C, Acio E, Burman K, Wartofsky L 2009 The utility of radio-iodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer. Thyroid 19:849-855.
17. Mcdougall R 2009 The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer. Thyroid 19:811-813.
18. Berson SA, Yallow RS 1954 Quantitative aspects of iodine metabolism: the exchangeable organic iodine pool and the rates of thyroid secretion, peripheral degradation and fecal excretion of endogenously synthesized organically bound iodine. J Clin Invest 33:1533-1552.
19. Freitas JE, Gross MD, Ripley, Shapiro B 1985 Radionuclide diagnosis and therapy of thyroid cancer: current status report. Semin Nucl Med 15:106-131.
20. Johnson PM 1978 Thyroid and whole-body scanning. In: Werner SC, Ingbar SH, (eds) The Thyroid: A Fundamental and Clinical Text, 4th edition. Harper & Row, Hagerston, PA, pp 247-297.
21. Maxon RH, Smith HS 1990 Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 19:685-718. (Pubitemid 20282663)
22. Riggs DS 1952 Quantitative aspects of iodine metabolism in man. Pharmacol Rev 4:283-293.
23. Sutter CW, Masilungan BG, Stadalnik RC 1995 False-positive results of I-131 whole-body scans in patients with thyroid cancer. Semin Nucl Med 25:279-282.
24. Zalis ED, Ellison RB, Captain MC, Barrett O Jr., Major MC 1965 A diagnostic pitfall with radioiodine scanning. Am J Roentgenol 94:837-838.
25. Wu S, Brown T, Milne N, Egbert R, Kabok A, Lyons KP, Hickey J 1986 Iodine-131 total body scan: extrathyroidal uptake of radioiodine. Semin Nucl Med 16:82-84.
26. Wolff J 1972 Iodide concentrating mechanisms. In: Tall JE, Kopin IJ, Berson SA (eds) The Thyroid and Biogenic Amines: Methods in Investigative and Diagnostic Endocrinology, vol 1. North-Holland Publishing Co, Amsterdam, pp 115-203.
27. Spitzweg C, Joba W, Eisenmenger W, Heufelder AE 1998 Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 83:1746-1751. (Pubitemid 28501052)
28. Wayne EJ, Koutras DA, Alexander WD (eds) 1964 Clinical Aspects of Iodine Metabolism. FA Davis Company, Philadelphia, PA, pp 1-303.
29. Fogelman I, Maisey MN 1989 The thyroid scan in the management of thyroid disease. In: Freeman LM, Weissmann HS (eds) Nuclear Medicine Annual. Raven Press, NY, p 1.
30. Ingui CJ, Shah NP, Oates ME 2006 Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis. Clin Nucl Med 31:665-672. (Pubitemid 44624550)
31. Bakheet SM, Hammami MM 1994 False positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology. Clin Nucl Med 19:325-329. (Pubitemid 24134149)
32. Datz FL 1995 Gamuts in Nuclear Medicine, 3rd edition. Mosby Yearbook, St. Louis, MO, pp 4-15.
33. Greenler DP, Klein HA 1989 The scope of false-positive iodine-131 images for thyroid carcinoma. Clin Nucl Med 14:111-117. (Pubitemid 19081824)
34. Geatti O, Shapiro B, Orsolon PG, Mirolo R, Di Donna A 1994 An unusual false positive scan in a patient with pericardial effusion. Clin Nucl Med 19:678-682. (Pubitemid 24307367)
35. Bakheet S, Powe J, Hammami M 1997 Radioiodine uptake in the chest. J Nucl Med 38:984-986. (Pubitemid 27251999)
36. Bakheet S, Hammami M, Powe J 1996 False-positive radio-iodine uptake in the abdomen and the pelvis: radioiodine retention in the kidneys and review of the literature. Clin Nucl Med 21:932-937. (Pubitemid 26412215)
37. Shapiro B, Rufini V, Jarwan A, Geatti O, Kearfott KJ, Fig LM, Kirkwood ID, Gross MD 2000 Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med 30:115-132. (Pubitemid 30211275)
38. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
39. Kloos RT 2009 Protecting thyroid cancer patients from untoward effects of radioactive iodine treatment. Thyroid 19:925-928.
40. Larkin A, Friedman K, Mahesh M, Noz M, Wagner S, Wahl R 2008 Quantifying the increase in radiation exposure associated with SPECT/CT compared to SPECT alone for routine nuclear medicine examinations. Med Phys 35:2675.
41. Sanz Viedma S, Borrego Dorado I, Rodriguez Rodriguez JR, Navarro Gonzalez E, Vazquez Albertino R, Fernandez Lopez R, Agudo Martinez A 2011 Use of (18F)FDG-PET in patients with suspicion of recurrent differentiated thyroid cancer by elevated antithyroglobulin antibodies levels and negative (131)I scan. Rev Esp Med Nucl 30:77-82.
42. Razfar A, Branstetter BFt, Christopoulos A, Lebeau SO, Hodak SP, Heron DE, Escott EJ, Ferris RL 2010 Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma. Arch Otolaryngol Head Neck Surg 136:120-125.
43. Dong MJ, Liu ZF, Zhao K, Ruan LX, Wang GL, Yang SY, Sun F, Luo XG 2009 Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis. Nucl Med Commun 30:639-650.
44. Bertagna F, Bosio G, Biasiotto G, Rodella C, Puta E, Gabanelli S, Lucchini S, Merli G, Savelli G, Giubbini R, Rosenbaum J, Alavi A 2009 F-18 FDG-PET/CT evaluation of patients with differentiated thyroid cancer with negative I-131 total body scan and high thyroglobulin level. Clin Nucl Med 34:756-761.
45. Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL 2008 Combined 18FFluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer. Ann Surg Oncol 15:286-292.
46. Van Nostrand D, Moreau S, Bandaru VV, Atkins F, Chen-nupati S, Mete M, Burman K, Wartofsky L 2010 (124)I positron emission tomography versus (131)I planar imaging in the identification of residual thyroid tissue and/or metastasis in patients who have well-differentiated thyroid cancer. Thyroid 20:879-883.
47. Phan HT, Jager PL, Paans AM, Plukker JT, Sturkenboom MG, Sluiter WJ, Wolffenbuttel BH, Dierckx RA, Links TP 2008 The diagnostic value of 124I-PET in patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35:958-965.
48. Freudenberg LS, Antoch G, Jentzen W, Pink R, Knust J, Gorges R, Muller SP, Bockisch A, Debatin JF, Brandau W 2004 Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol 14:2092-2098. (Pubitemid 39481183)